Interpretation of JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis
10.12290/xhyxzz.2023-0630
- VernacularTitle:《2023年JCS心肌炎诊断和治疗指南》解读
- Author:
Song ZHANG
1
;
Luhong QIU
2
;
Yingxian LIU
2
;
Xiqi XU
2
Author Information
1. Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
2. Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
- Publication Type:Journal Article
- Keywords:
myocarditis;
endomyocardial biopsy;
classification;
treatment
- From:
Medical Journal of Peking Union Medical College Hospital
2024;15(2):320-327
- CountryChina
- Language:Chinese
-
Abstract:
JCS 2023 Guideline on the Diagnosis and Treatment of Myocarditis offers a new perspective on the definition, classification, epidemiology, pathophysiology, diagnosis, diagnostic, treatment and management of myocarditis. It also provides recommendations to clinicians on the diagnosis and treatment of myocarditis which are more suitable for clinical practice. Given that no myocarditis guidance document has recently been issued in China, this article provides a comprehensive interpretation of the key points of this guideline combined with the latest research, so as to provide reference for the diagnosis and treatment of myocarditis in our country.
